451 related articles for article (PubMed ID: 21148540)
1. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
[TBL] [Abstract][Full Text] [Related]
2. Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction.
Delewi R; van der Laan AM; Robbers LF; Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; Tio RA; Waltenberger J; Ten Berg JM; Doevendans PA; Gehlmann HR; van Rossum AC; Piek JJ; Zijlstra F;
Heart; 2015 Mar; 101(5):363-8. PubMed ID: 25294647
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tio RA; van der Giessen WJ; Marques KM; Doevendans PA; Waltenberger J; Ten Berg JM; Aengevaeren WR; Biemond BJ; Tijssen JG; van Rossum AC; Piek JJ; Zijlstra F
Catheter Cardiovasc Interv; 2008 Feb; 71(3):273-81. PubMed ID: 18288734
[TBL] [Abstract][Full Text] [Related]
7. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
[TBL] [Abstract][Full Text] [Related]
8. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial.
van der Laan AM; Hirsch A; Haeck JD; Nijveldt R; Delewi R; Biemond BJ; Tijssen JG; Marques KM; Zijlstra F; van Rossum AC; Piek JJ
JACC Cardiovasc Interv; 2011 Aug; 4(8):913-20. PubMed ID: 21851907
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
[TBL] [Abstract][Full Text] [Related]
10. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
Beitnes JO; Gjesdal O; Lunde K; Solheim S; Edvardsen T; Arnesen H; Forfang K; Aakhus S
Eur J Echocardiogr; 2011 Feb; 12(2):98-106. PubMed ID: 20851818
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
15. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
[TBL] [Abstract][Full Text] [Related]
18. Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction.
Kang HJ; Kim MK; Lee HY; Park KW; Lee W; Cho YS; Koo BK; Choi DJ; Park YB; Kim HS
Eur Heart J; 2012 Dec; 33(24):3062-9. PubMed ID: 22904565
[TBL] [Abstract][Full Text] [Related]
19. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS
Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
